CoreAge Rx vs Trinity Meds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Trinity Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 59 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Trinity Meds a bad call — it's best for people considering a bundled telehealth program who confirm the actual medication and full-term payment before accepting its final-sale policy. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Trinity Meds |
|---|---|---|
| Brief Score | 94/100 (A) | 59/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Named medication and full quote unconfirmed Advertised GLP-1 $99/mo or GLP-1/GIP $149/mo; exact named prescription, supply, full-term payment and required clinical services need confirmation. Payments final at purchase, including unused/unshipped multi-month portions. Cancel at least 72 hours before billing; medical-disqualification refund deducts already used services. Full price detailsCurrent named semaglutide prescription and complete selected-plan quote unknown; program advertises GLP-1 $99/month or GLP-1/GIP $149/month without molecule-specific dose or supply confirmation |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Named medication and full quote unconfirmed Advertised GLP-1 $99/mo or GLP-1/GIP $149/mo; exact named prescription, supply, full-term payment and required clinical services need confirmation. Payments final at purchase, including unused/unshipped multi-month portions. Cancel at least 72 hours before billing; medical-disqualification refund deducts already used services. Full price detailsCurrent named tirzepatide prescription and complete selected-plan quote unknown; program advertises GLP-1 $99/month or GLP-1/GIP $149/month without molecule-specific dose or supply confirmation |
| Coverage | US only; restrictions by state, confirmed at intake | Terms say all 50 states plus Washington DC, subject to independent clinician and pharmacy eligibility for the patient location |
| Brand-name access | Not confirmed | The current class-level compounded program does not establish a named branded GLP-1 offer or an individual prescription preparation. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Trinity Meds: Class-level GLP-1 $99/GLP-1-GIP $149; named medication and complete quote unconfirmed. Payments final at purchase; cancel 72 hours before renewal. Medical-disqualification refund deducts used services.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.